Pure Global

Multiple congenital aneuploidy screening IVD, kit, nucleic acid technique (NAT) - UK MHRA Medical Device Registration

Multiple congenital aneuploidy screening IVD, kit, nucleic acid technique (NAT) is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 95027. The device is manufactured by Roche Sequencing Solutions, Inc. from United States, classified as In Vitro Diagnostic Device. The authorized representative in the UK is Roche Diagnostics Limited.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, authorized representative details, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
MHRA Registered
In Vitro Diagnostic Device
๐Ÿ‡ฌ๐Ÿ‡ง
Multiple congenital aneuploidy screening IVD, kit, nucleic acid technique (NAT)
MHRA Device ID: 95027โ€ขRef: 95027

Device Type

In Vitro Diagnostic Device

Devices

Multiple congenital aneuploidy screening IVD, kit, nucleic acid technique (NAT)

Type

IVD Annex II List B

Date Registered

Sep 1, 2024

Last Updated

Jul 10, 2024

Manufacturer Information

Address

4300 Hacienda Dr.

Pleasanton, United States

Created Date

Aug 16, 2021

Authorized Representative

Relationship Type

UK Responsible Person

Address

Roche Diagnostics Limited Charles Avenue

Burgess Hill, West Sussex, United Kingdom

Postcode: RH15 9RY

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing